Bacteriological Profile and Antimicrobial Resistance Patterns in Ventilator-Associated Pneumonia: A Prospective Study from a Tertiary Care Center in Eastern India
The Journal of Association of Chest Physicians · 2026-01 · 14 (1) · 22-26
DOI: 10.4103/jacp.jacp_39_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Association of Chest Physicians, online erschienen am 24.04.2026. Verfasst von Jharana Mahanta und 6 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Pneumonieprophylaxe
Abstract (Originalsprache)
Background
Ventilator-associated pneumonia (VAP) is a major cause of morbidity and mortality in critically ill patients requiring mechanical ventilation. The increasing burden of multidrug-resistant (MDR) organisms has complicated treatment and outcomes. This study aimed to determine the bacteriological profile, antimicrobial resistance patterns, and clinical outcomes in patients with VAP in a tertiary-care intensive care unit (ICU) in Eastern India.
Methods
This prospective observational study (February 2020–January 2022) included adults undergoing invasive mechanical ventilation for >48 hours who developed clinical suspicion of VAP , defined as new or progressive radiographic infiltrates plus ≥2 clinical features (fever/hypothermia, leukocytosis/leukopenia, purulent secretions, or worsening oxygenation). VAP was microbiologically confirmed by quantitative endotracheal aspirate culture ≥10 5 CFU/mL. Bacterial identification used standard biochemical methods, and antimicrobial susceptibility testing followed CLSI 2023 guidelines. Colistin minimum inhibitory concentrations were determined by broth microdilution. MDR was defined as nonsusceptibility to ≥1 agent in ≥3 antimicrobial classes.
Results
Of 200 clinically suspected VAP cases, 76 (38%) were microbiologically confirmed. Early-onset VAP constituted 38.15% and late-onset VAP 61.85%. A total of 100 isolates were recovered; 91% were gram-negative bacilli, predominantly Klebsiella spp. (36%), Acinetobacter spp. (25%), and Pseudomonas spp. (24%). Over 90% of gram-negative isolates were resistant to third-generation cephalosporins and fluoroquinolones. Colistin resistance was identified in 5.49% of isolates. MDR prevalence was 73% overall, and was highest in late-onset VAP (76.5%). Mortality among culture-confirmed VAP patients was 48.68%.
Conclusion
MDR gram-negative organisms remain the predominant etiological agents of VAP in this ICU setting, with emerging colistin resistance posing additional therapeutic challenges. These findings reinforce the need for ongoing surveillance, local antibiograms, and strengthened antimicrobial stewardship to optimize therapy and improve clinical outcomes.
Zitieren
APA
Mahanta, J., Mohanta, P. C., Sahoo, K. C., Jagaty, S. K., Mishra, S., Biswal, S. P., & Panda, R. K. (2026). Bacteriological Profile and Antimicrobial Resistance Patterns in Ventilator-Associated Pneumonia: A Prospective Study from a Tertiary Care Center in Eastern India. The Journal of Association of Chest Physicians, 14(1), 22-26. https://doi.org/10.4103/jacp.jacp_39_25
Vancouver
Mahanta J, Mohanta PC, Sahoo KC, Jagaty SK, Mishra S, Biswal SP, et al. Bacteriological Profile and Antimicrobial Resistance Patterns in Ventilator-Associated Pneumonia: A Prospective Study from a Tertiary Care Center in Eastern India. The Journal of Association of Chest Physicians. 2026;14(1):22-26. doi:10.4103/jacp.jacp_39_25
BibTeX
@article{Mahanta2026,
author = {Mahanta, Jharana and Mohanta, Paresh Chandra and Sahoo, Kshirod Chandra and Jagaty, Suman Kumar and Mishra, Swadip and Biswal, Sudhansu Priyadarsini and Panda, Rakesh Kumar},
title = {Bacteriological Profile and Antimicrobial Resistance Patterns in Ventilator-Associated Pneumonia: A Prospective Study from a Tertiary Care Center in Eastern India},
journal = {The Journal of Association of Chest Physicians},
year = {2026},
volume = {14},
number = {1},
pages = {22--26},
doi = {10.4103/jacp.jacp_39_25}
}
EUVIMED